Oncology-Derived Strategies For Age-Related Diseases: Intersections Of Oncogenesis, Senescence, And Immunity
Have you ever wondered if the fight against cancer could also help us combat aging? Recent research suggests a fascinating connection: the very biological processes that drive cancer growth are often the same ones that contribute to the aging of our bodies. This means that understanding and targeting these shared pathways could offer a dual benefit, potentially leading to new ways to treat both cancer and age-related conditions.
Our cells naturally undergo a process called senescence, where they stop dividing, often in response to damage. While this can initially protect against cancer by preventing damaged cells from multiplying, the accumulation of these senescent cells over time can actually contribute to aging and increase the risk of diseases. Furthermore, as we age, our immune system, which is crucial for fighting off diseases, becomes less effective at clearing out these problematic cells.
Excitingly, therapies originally developed for cancer, such as those that selectively eliminate senescent cells (called senolytics), modify metabolism, or boost the immune system (immunotherapies), are now being explored for their potential to mitigate the degenerative effects of aging. By restoring the immune system’s ability to recognize and remove harmful cells, and by targeting the molecular pathways common to both cancer and aging, we might be able to develop innovative strategies to promote healthier aging. This approach, however, requires careful consideration to ensure that treatments designed for one complex condition can be safely and effectively adapted for another.
Source: link to paper